Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
     422  Antimetabolites
     423  Antibiotics
     424  Plant extract preparations
     429  Miscellaneous
       4291  Other Antitumors
         D00068  Alcohol (USP); Anhydrous ethanol (JP18)
         D00094  Tretinoin (JAN/USP/INN)
         D09960  Ruxolitinib phosphate (JAN/USAN)
         D01370  Cladribine (JAN/USP/INN)
         D03021  Azacitidine (JAN/USAN/INN)
         D06199  Trabectedin (JAN/USAN/INN)
         D02166  Mitoxantrone hydrochloride (JAN/USP)
         D01441  Imatinib mesylate (USAN); Imatinib mesilate (JAN)
         D03658  Dasatinib (JAN/INN)
         D06414  Dasatinib (USAN); Dasatinib hydrate (JAN)
         D06413  Nilotinib hydrochloride hydrate (JAN)
         D09728  Bosutinib hydrate (JAN)
         D09951  Ponatinib hydrochloride (JAN/USAN)
         D11404  Asciminib hydrochloride (JAN/USAN)
         D01977  Gefitinib (JP18/USAN/INN)
         D04023  Erlotinib hydrochloride (JAN/USAN)
         D09733  Afatinib dimaleate (USAN); Afatinib maleate (JAN)
         D10766  Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)
         D10514  Dacomitinib (USAN); Dacomitinib hydrate (JAN)
         D12245  Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN)
         D09996  Vemurafenib (JAN/USAN/INN)
         D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN)
         D11053  Encorafenib (JAN/USAN/INN)
         D09731  Crizotinib (JAN/USAN/INN)
         D10551  Ceritinib (JAN/USAN/INN)
         D10450  Alectinib hydrochloride (JAN)
         D10866  Brigatinib (JAN/USAN)
         D11012  Lorlatinib (JAN/USAN/INN)
         D10176  Trametinib dimethyl sulfoxide (JAN/USAN)
         D10604  Binimetinib (JAN/USAN/INN)
         D10372  Palbociclib (JAN/USAN)
         D10688  Abemaciclib (JAN/USAN/INN)
         D06068  Temsirolimus (JAN/USAN/INN)
         D02714  Everolimus (JAN/USAN/INN)
         D00753  Sirolimus (JAN/USAN/INN)
         D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)
         D11296  Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN)
         D10889  Momelotinib hydrochloride hydrate (JAN)
         D03218  Axitinib (JAN/USAN)
         D11977  Fruquintinib (JAN/USAN)
         D10223  Ibrutinib (JAN/USAN)
         D10893  Acalabrutinib (JAN/USAN/INN)
         D12704  Acalabrutinib maleate hydrate (JAN)
         D11422  Zanubrutinib (JAN/USAN/INN)
         D12050  Pirtobrutinib (JAN/USAN)
         D11070  Tirabrutinib hydrochloride (JAN/USAN)
         D10927  Erdafitinib (JAN/USAN/INN)
         D11417  Pemigatinib (JAN/USAN/INN)
         D11725  Futibatinib (JAN/USAN/INN)
         D06402  Sunitinib malate (JAN/USAN)
         D06272  Sorafenib tosylate (USAN); Sorafenib tosilate (JAN)
         D05380  Pazopanib hydrochloride (JAN/USAN)
         D06407  Vandetanib (JAN/USAN/INN)
         D10137  Regorafenib hydrate (JAN)
         D10095  Cabozantinib s-malate (USAN); Cabozantinib malate (JAN)
         D09920  Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)
         D09956  Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN)
         D11138  Larotrectinib sulfate (JAN/USAN)
         D10800  Gilteritinib fumarate (JAN/USAN)
         D10926  Entrectinib (JAN/USAN/INN)
         D10891  Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN)
         D11073  Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN)
         D11713  Selpercatinib (JAN/USAN/INN)
         D11371  Capivasertib (JAN/USAN)
         D11454  Repotrectinib (JAN/USAN)
         D02994  Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN)
         D09321  Obinutuzumab (USAN/INN); Obinutuzumab (genetical recombination) (JAN)
         D10777  Daratumumab (USAN); Daratumumab (genetical recombination) (JAN)
         D11967  Daratumumab and hyaluronidase
         D11050  Isatuximab (USAN/INN); Isatuximab (genetical recombination) (JAN)
         D03257  Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN)
         D05446  Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN)
         D09980  Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN)
         D11529  Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN)
         D03455  Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN)
         D05350  Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN)
         D10018  Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN)
         D10316  Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)
         D10574  Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN)
         D10808  Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN)
         D10817  Avelumab (USAN/INN); Avelumab (genetical recombination) (JAN)
         D10773  Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN)
         D11108  Cemiplimab (USAN); Cemiplimab (genetical recombination) (JAN)
         D11487  Tislelizumab (USAN/INN); Tislelizumab (genetical recombination) (JAN)
         D06409  Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
         D09371  Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN)
         D04603  Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN)
         D09587  Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN)
         D10559  Dinutuximab (USAN/INN); Dinutuximab (genetical recombination) (JAN)
         D09325  Blinatumomab (USAN/INN); Blinatumomab (genetical recombination) (JAN)
         D09337  Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN)
         D09761  Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN)
         D11525  Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN)
         D10761  Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN)
         D11595  Belantamab mafodotin (USAN); Belantamab mafodotin (genetical recombination) (JAN)
         D10985  Sacituzumab govitecan (USAN/INN); Sacituzumab govitecan (genetical recombination) (JAN)
         D11894  Amivantamab (USAN/INN); Amivantamab (genetical recombination) (JAN)
         D06657  Tremelimumab (USAN/INN); Tremelimumab (genetical recombination) (JAN)
         D11814  Tisotumab vedotin (USAN/INN); Tisotumab vedotin (genetical recombination) (JAN)
         D12177  Teclistamab (USAN/INN); Teclistamab (genetical recombination) (JAN)
         D11463  Mosunetuzumab (USAN/INN); Mosunetuzumab (genetical recombination) (JAN)
         D12368  Epcoritamab (USAN/INN); Epcoritamab (genetical recombination) (JAN)
         D12180  Talquetamab (USAN/INN); Talquetamab (genetical recombination) (JAN)
         D11527  Zolbetuximab (USAN/INN); Zolbetuximab (genetical recombination) (JAN)
         D12058  Elranatamab (USAN); Elranatamab (genetical recombination) (JAN)
         D12234  Tarlatamab (USAN); Tarlatamab (genetical recombination) (JAN)
         D12359  Datopotamab deruxtecan (USAN/INN); Datopotamab deruxtecan (genetical recombination) (JAN)
         D11934  Pertuzumab, trastuzumab and hyaluronidase
         D00275  Cisplatin (JP18/USP/INN)
         D01363  Carboplatin (JP18/USP/INN)
         D01790  Oxaliplatin (JP18/USP/INN)
         D00478  Procarbazine hydrochloride (JP18/USP)
         D03106  Bexarotene (JAN/USAN/INN)
         D03150  Bortezomib (JAN/USAN/INN)
         D12311  Bortezomib hydrate (JAN)
         D08880  Carfilzomib (JAN/USAN/INN)
         D10131  Ixazomib citrate (JAN/USAN)
         D06320  Vorinostat (JAN/USAN)
         D06637  Romidepsin (JAN/USAN/INN)
         D10993  Tucidinostat (JAN/USAN/INN)
         D09730  Olaparib (JAN/USAN/INN)
         D11895  Niraparib tosylate (USAN); Niraparib tosilate hydrate (JAN)
         D10733  Talazoparib tosylate (USAN); Talazoparib tosilate (JAN)
         D11090  Ivosidenib (JAN/USAN/INN)
         D02997  Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN)
         D10517  Crisantaspase (JAN/INN)
         D02106  Arsenic trioxide (JP18/USAN)
         D03682  Denileukin diftitox (USAN/INN); Denileukin difitox (genetical recombination) (JAN)
         D08914  Eribulin mesylate (USAN); Eribulin mesilate (JP18)
         D10679  Venetoclax (JAN/USAN/INN)
         D11485  Tazemetostat hydrobromide (JAN/USAN)
         D12055  Sotorasib (JAN/USAN)
         D11954  Belzutifan (JAN/USAN/INN)
         D08898  Darinaparsin (JAN/USAN)
         D11390  Daunorubicin and cytarabine
         D00966  Tamoxifen citrate (JP18/USP)
         D00967  Toremifene citrate (JAN/USAN)
         D01161  Fulvestrant (JAN/USP/INN)
         D00586  Flutamide (JP18/USP/INN)
         D00961  Bicalutamide (JP18/USP/INN)
         D10218  Enzalutamide (JAN/USAN)
         D11040  Apalutamide (JAN/INN)
         D11045  Darolutamide (JAN/USAN/INN)
         D00960  Anastrozole (JP18/USP/INN)
         D00964  Letrozole (JAN/USP/INN)
         D00963  Exemestane (JAN/USP/INN)
         D09701  Abiraterone acetate (JAN/USP)
         D11027  Ropeginterferon alfa-2b (INN); Ropeginterferon alfa-2b (genetical recombination) (JAN)
         D02802  Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN)
         D00754  Thalidomide (JAN/USP/INN)
         D04687  Lenalidomide (JAN/USAN/INN)
         D09813  Lenalidomide hydrate (JAN)
         D08976  Pomalidomide (JAN/USAN/INN)
         D03308  Iobenguane I 131 (USP); 3-Iodobenzylguanidine (131I) (JAN)
         D10398  Radium Ra 223 dichloride (USAN)
         D11033  Lutetium (177Lu) oxodotreotide (INN)
         D01404  Sobuzoxane (JAN)
         D01416  Nedaplatin (JAN/INN)
         D01418  Tamibarotene (JAN/USAN/INN)
         D04245  Forodesine hydrochloride (JAN/USAN)
         D06294  Miriplatin hydrate (JAN)
         D10819  Aflibercept beta (genetical recombination) (JAN)
         D11272  Borofalan (10B) (JAN)
         D11662  Valemetostat tosilate (JAN)
         D11920  Pimitespib (JAN)
         D12405  Tasurgratinib succinate (JAN)
         D12705  Gumarontinib hydrate (JAN)
       4299  Others
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 5, 2025
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version